Difference between revisions of "LncRNA-ATB"

From LncRNAWiki
Jump to: navigation, search
(Created page with "==Annotation== ===Name=== lncRNA-ATB ===Alias=== NA ===Disease=== Disease: colorectal cancer [http://www.ncbi.nlm.nih.gov/pubmed/26487301 (PMID:26487301)] Dysfunction type:...")
 
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
 +
''LncRNA-ATB'', a Long Noncoding RNA activated by TGF-β associated with poor prognosis in Hepatocellular Carcinoma (HCC)
 
==Annotation==
 
==Annotation==
 
===Name===
 
===Name===
lncRNA-ATB
+
''LncRNA-ATB'', Long Noncoding RNA activated by TGF-β <ref name="ref1" />
  
 
===Alias===
 
===Alias===
 
NA
 
NA
  
===Disease===
+
===Characteristics===
Disease: colorectal cancer [http://www.ncbi.nlm.nih.gov/pubmed/26487301 (PMID:26487301)]
+
''LncRNA-ATB'' is a long noncoding RNA which is primarily activated by Transforming  Growth Factor β (TGF-β) has been reported to be involved in specific physiological and pathological processes in human diseases, and could serve as biomarkers for cancers. ''LncRNA-ATB'' is poly (A)-negative and mainly located in the cytoplasm. ''LncRNA-ATB'' has no protein-coding potential since analysis of the sequences by ORF Finder from the National Center for Biotechnology  Information failed to predict a protein of more than 55 amino acids. Moreover, ''lncRNA-ATB'' does not contain a valid Kozak sequence. <ref name="ref1" />
  
Dysfunction type: interaction
+
===Function===
 +
''LncRNA-ATB'' downregulates E-cadherin (E-cad) and induces epithelial-to- mesenchymal transition thereby promoting the invasion-metastasis in carcinoma. <ref name="ref2" />
 +
 
 +
''LncRNA-ATB'' also competitively binds the miR-200 family and then induces EMT and invasion by upregulating ZEB1 and ZEB2. lncRNA-ATB promotes EMT, HCC cell invasion, and metastatic organ colonization. ''LncRNA-ATB'' promotes organ colonization of disseminated tumor cells by binding IL-11 mRNA, autocrine induction of IL-11, and triggering STAT3 signaling. ''LncRNA-ATB'', as a mediator of TGF-β signaling, could predispose HCC patients to metastases and may serve as a potential target for antimetastatic therapies. <ref name="ref1" />
 +
 
 +
===Regulation===
 +
''LncRNA-ATB'' is regulated by Transforming  Growth Factor β (TGF-β). Studies indicated that a short-term TGF-β treatment was sufficient to activate ''lncRNA-ATB'', which implied that ''lncRNA-ATB'' may be a direct target of TGF-β/Smad pathway, but how TGF-β activates ''lncRNA-ATB'' requires further investigation.<ref name="ref1" /> Long non-coding RNA-activated by TGF-β was upregulated in colon cancer tissues compared with adjacent mucosa. ''LncRNA-ATB'' levels were also higher in metastatic cancer tissues <ref name="ref2" />
  
Description: LncRNA-ATB was upregulated in colon cancer tissues compared with adjacent mucosa. LncRNA-ATB levels were also higher in metastatic cancer tissues. Among the three highly invasive colon cancer cell lines, lncRNA-ATB levels were relatively higher with concurrent low levels of E-cad compared with levels in the three low-invasive cell lines. LncRNA-ATB expression correlated with pN stage and AJCC stage. Striking differences were observed in overall survival and disease-free survival in cases with both high lncRNA-ATB expression and low E-cad expression. Reduction of lncRNA-ATB increased expression of epithelial markers E-cad, ZO-1, and decreased expression of mesenchymal markers ZEB1 and N-cadherin (N-cad), and significantly influenced colon cancer cell progression. Plasma lncRNA-ATB was upregulated in colon cancer patients one month after surgery.
+
===Expression===
 +
[[File: lncrna-ATB.jpg|right|thumb|400px|'''Scatter plots of ''lncRNA-ATB'' expressions in different groups. Solid circles, healthy controls; Solid squares, healthy coal miners; Solid triangles, CWP patients. (* p < 0.05).''' <ref name="ref3" />.]]
 +
High level expression of ''lncRNA-ATB'' is associated with liver cirrhosis in patients with HCC and poor prognosis. High expression of ''lncRNA-ATB'' is a robust predictor of poor survival. ''LncRNA-ATB'' was activated by TGF-β and induced EMT not only in HCC cells, but also in colorectal cancer and breast cancer cells. <ref name="ref1" /> Striking differences were observed in overall survival and disease-free survival in cases with both high ''lncRNA-ATB'' expression and low E-cad expression. Reduction of ''lncRNA-ATB'' increased expression of epithelial markers E-cad, ZO-1, and decreased expression of mesenchymal markers ZEB1 and N-cadherin (N-cad), and significantly influenced colon cancer cell progression.<ref name="ref2" /> ''LncRNA-ATB'' expression is also commonly increased in Coal Workers’ Pneumoconiosis (CWP) and significantly correlates with the TGF-β1 in CWP patients. Furthermore, elevated ''lncRNA-ATB'' was associated with CWP risk and may serve as a potential biomarker for CWP.<ref name="ref3" />
  
 +
{| class='wikitable' style="text-align:center"
 +
|-
 +
! | Experiment
 +
! | Forward primer
 +
! | Reverse primer
 +
|-
 +
| rowspan="1"|qRT-PCR
 +
| | 5'-CTTCACCAGCACCCAGAGA- 3'
 +
| | 5'-AAGACAGAAAAACAGTTCCGAGTC- 3'<ref name="ref3" />
 +
|}
  
===Function===
+
===Diseases===
Function Mechanism: NA [http://www.ncbi.nlm.nih.gov/pubmed/27556453 (PMID:27556453)]
+
*Breast cancer <ref name="ref1" />
 +
*Coal Workers’ Pneumoconiosis CWP <ref name="ref3" />
 +
*Colorectal cancer <ref name="ref2" />
 +
*Hepatocellular Carcinoma HCC <ref name="ref1" />
  
Biological Process: pathogenic process
+
==Labs Working==
 +
*Department of Medical Genetics, Second Military Medical University, Shanghai, 200433, China
 +
*The Third Department of Hepatic Surgery, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai, 200433, China
 +
*The Fifth Department of Hepatic Surgery, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai, 200433, China
 +
*Department of General Surgery, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, China
 +
*Department of Occupational & Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
 +
*Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
 +
*Long Hua Center for Disease Control and Prevention, Shenzhen 518109, China
  
Description: biomarker
+
==Reference==
 +
<references>
 +
<ref name="ref1"> Yuan J-h, Yang F, Wang F, Ma J-z, Guo Y-j, Tao Q-f et al. A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma[J]. Cancer Cell. 2014, 25(5):666-681.</ref>(1)
 +
<ref name="ref2"> Yue B, Qiu S, Zhao S, Liu C, Zhang D, Yu F et al. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis[J]. Journal of Gastroenterology and Hepatology. 2016, 31(3):595-603.</ref>(2)
 +
<ref name="ref3"> Ma J, Cui X, Rong Y, Zhou Y, Guo Y, Zhou M et al. Plasma LncRNA-ATB, a Potential Biomarker for Diagnosis of Patients with Coal Workers' Pneumoconiosis: A Case-Control Study[J]. International journal of molecular sciences. 2016, 17(8):1367.</ref>(3)
 +
</references>

Latest revision as of 05:06, 20 November 2018

LncRNA-ATB, a Long Noncoding RNA activated by TGF-β associated with poor prognosis in Hepatocellular Carcinoma (HCC)

Annotation

Name

LncRNA-ATB, Long Noncoding RNA activated by TGF-β [1]

Alias

NA

Characteristics

LncRNA-ATB is a long noncoding RNA which is primarily activated by Transforming Growth Factor β (TGF-β) has been reported to be involved in specific physiological and pathological processes in human diseases, and could serve as biomarkers for cancers. LncRNA-ATB is poly (A)-negative and mainly located in the cytoplasm. LncRNA-ATB has no protein-coding potential since analysis of the sequences by ORF Finder from the National Center for Biotechnology Information failed to predict a protein of more than 55 amino acids. Moreover, lncRNA-ATB does not contain a valid Kozak sequence. [1]

Function

LncRNA-ATB downregulates E-cadherin (E-cad) and induces epithelial-to- mesenchymal transition thereby promoting the invasion-metastasis in carcinoma. [2]

LncRNA-ATB also competitively binds the miR-200 family and then induces EMT and invasion by upregulating ZEB1 and ZEB2. lncRNA-ATB promotes EMT, HCC cell invasion, and metastatic organ colonization. LncRNA-ATB promotes organ colonization of disseminated tumor cells by binding IL-11 mRNA, autocrine induction of IL-11, and triggering STAT3 signaling. LncRNA-ATB, as a mediator of TGF-β signaling, could predispose HCC patients to metastases and may serve as a potential target for antimetastatic therapies. [1]

Regulation

LncRNA-ATB is regulated by Transforming Growth Factor β (TGF-β). Studies indicated that a short-term TGF-β treatment was sufficient to activate lncRNA-ATB, which implied that lncRNA-ATB may be a direct target of TGF-β/Smad pathway, but how TGF-β activates lncRNA-ATB requires further investigation.[1] Long non-coding RNA-activated by TGF-β was upregulated in colon cancer tissues compared with adjacent mucosa. LncRNA-ATB levels were also higher in metastatic cancer tissues [2]

Expression

Scatter plots of lncRNA-ATB expressions in different groups. Solid circles, healthy controls; Solid squares, healthy coal miners; Solid triangles, CWP patients. (* p < 0.05). [3].

High level expression of lncRNA-ATB is associated with liver cirrhosis in patients with HCC and poor prognosis. High expression of lncRNA-ATB is a robust predictor of poor survival. LncRNA-ATB was activated by TGF-β and induced EMT not only in HCC cells, but also in colorectal cancer and breast cancer cells. [1] Striking differences were observed in overall survival and disease-free survival in cases with both high lncRNA-ATB expression and low E-cad expression. Reduction of lncRNA-ATB increased expression of epithelial markers E-cad, ZO-1, and decreased expression of mesenchymal markers ZEB1 and N-cadherin (N-cad), and significantly influenced colon cancer cell progression.[2] LncRNA-ATB expression is also commonly increased in Coal Workers’ Pneumoconiosis (CWP) and significantly correlates with the TGF-β1 in CWP patients. Furthermore, elevated lncRNA-ATB was associated with CWP risk and may serve as a potential biomarker for CWP.[3]

Experiment Forward primer Reverse primer
qRT-PCR 5'-CTTCACCAGCACCCAGAGA- 3' 5'-AAGACAGAAAAACAGTTCCGAGTC- 3'[3]

Diseases

  • Breast cancer [1]
  • Coal Workers’ Pneumoconiosis CWP [3]
  • Colorectal cancer [2]
  • Hepatocellular Carcinoma HCC [1]

Labs Working

  • Department of Medical Genetics, Second Military Medical University, Shanghai, 200433, China
  • The Third Department of Hepatic Surgery, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai, 200433, China
  • The Fifth Department of Hepatic Surgery, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai, 200433, China
  • Department of General Surgery, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, China
  • Department of Occupational & Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • Long Hua Center for Disease Control and Prevention, Shenzhen 518109, China

Reference

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Yuan J-h, Yang F, Wang F, Ma J-z, Guo Y-j, Tao Q-f et al. A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma[J]. Cancer Cell. 2014, 25(5):666-681.
  2. 2.0 2.1 2.2 2.3 Yue B, Qiu S, Zhao S, Liu C, Zhang D, Yu F et al. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis[J]. Journal of Gastroenterology and Hepatology. 2016, 31(3):595-603.
  3. 3.0 3.1 3.2 3.3 Ma J, Cui X, Rong Y, Zhou Y, Guo Y, Zhou M et al. Plasma LncRNA-ATB, a Potential Biomarker for Diagnosis of Patients with Coal Workers' Pneumoconiosis: A Case-Control Study[J]. International journal of molecular sciences. 2016, 17(8):1367.